Application of CL Detect™ rapid test for diagnosis and liposomal amphotericin B for treatment of cutaneous leishmaniasis: A retrospective analysis from a tertiary care centre in a non-endemic area in India
Indian Journal of Dermatology, Venereology and Leprology · 2023
DOI: 10.25259/ijdvl_1017_2022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Dermatology, Venereology and Leprology, 2023. Verfasst von Priya Yadav und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biology Laboratory, ICMR-National Institute of Pathology, Safdarjung Hospital Campus, New Delhi, India. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Leishmaniasis, Cutaneous, Amphotericin B. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background
Increasing urbanisation has led to the occurrence of cutaneous leishmaniasis (CL) in new areas, which was otherwise localised to endemic areas. Healthcare workers should be made aware of this entity to ensure clinical suspicion of CL and investigations needed to confirm CL. The article describes patients seen at a tertiary hospital in Delhi.
Aims
To establish the utility of the CL Detect Rapid test as a diagnostic tool and the efficacy of Liposomal Amphotericin B (LAmB) for the complete cure of CL patients.
Methods
Data of patients of CL ( n = 16) was retrospectively analysed concerning diagnosis and treatment. Diagnosis rested on histopathology, real-time PCR, and CL Detect Rapid Test. Speciation of the parasite was based on the Internal transcribed spacer-I gene. Patients were treated with LAmB (i.v., 5 mg/kg up to three doses, five days apart).
Results
A positivity of 81.3% (95%CI, 54.4–96) was observed for CL Detect Rapid test in comparison with 100% (95%CI, 79.4–100.0) for real-time PCR and 43.8% (95%CI, 19.8–70.1) for microscopy/histopathological examination. L. tropica was the infective species in all cases. All the patients treated with LAmB responded to treatment, and 9/10 patients demonstrated complete regression of lesions, while one was lost to follow-up.
Limitations
It is a retrospective study, and the data includes only confirmed cases of CL at a single centre.
Conclusion
This study highlights the utility of CL Detect as a promising diagnostic tool and the efficacy of LAmB for the complete cure of CL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Biology Laboratory, ICMR-National Institute of Pathology, Safdarjung Hospital Campus, New Delhi, India.
- Department of Dermatology & STD, Safdarjang Hospital & VMMC, New Delhi, India.
- Department of Pathology, ICMR National Institute of Pathology, Safdardung Hospital Campus, New Delhi, India.
Zitieren
APA
Yadav, P., Ramesh, V., Avishek, K., Kathuria, S., Khunger, N., Sharma, S., Salotra, P., & Singh, R. (2023). Application of CL Detect™ rapid test for diagnosis and liposomal amphotericin B for treatment of cutaneous leishmaniasis: A retrospective analysis from a tertiary care centre in a non-endemic area in India. Indian Journal of Dermatology, Venereology and Leprology. https://doi.org/10.25259/ijdvl_1017_2022
Vancouver
Yadav P, Ramesh V, Avishek K, Kathuria S, Khunger N, Sharma S, et al. Application of CL Detect™ rapid test for diagnosis and liposomal amphotericin B for treatment of cutaneous leishmaniasis: A retrospective analysis from a tertiary care centre in a non-endemic area in India. Indian Journal of Dermatology, Venereology and Leprology. 2023. doi:10.25259/ijdvl_1017_2022
BibTeX
@article{Yadav2023,
author = {Yadav, Priya and Ramesh, V and Avishek, Kumar and Kathuria, Sushruta and Khunger, Niti and Sharma, Shruti and Salotra, Poonam and Singh, Ruchi},
title = {Application of CL Detect™ rapid test for diagnosis and liposomal amphotericin B for treatment of cutaneous leishmaniasis: A retrospective analysis from a tertiary care centre in a non-endemic area in India},
journal = {Indian Journal of Dermatology, Venereology and Leprology},
year = {2023},
doi = {10.25259/ijdvl_1017_2022}
}
EUVIMED